David Coman
Chief Executive Officer at Science 37 Holdings, Inc. (SNCE)
David Coman has filed 8 insider reports with the SEC since October 2021, as chief Executive Officer at Science 37 Holdings, Inc. (SNCE) and officer and director at Science 37 Holdings, Inc. (LSAQ). The latest filing, on March 12, 2024, reports sale back to the company and tender of shares in a change of control at Science 37 Holdings, Inc. (SNCE).
- Filings
- 8
- Companies
- 2
- Bought on market
- None
- Sold on market
- None
Companies where David Coman is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Chief Executive Officer | 0 | Mar 12, 2024 | |||||
| Officer, Directorsince October 2021 | 726,137 | Oct 13, 2021 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Mar 12, 2024SNCEComan David returned $176,991 worth of shares to the company (30,781 units at $5.75), closing all direct ownership in the companyForm 4Sale back to the companyTender of shares in a change of control
- Aug 12, 2023SNCESEC Form 4: Coman David converted options into 495,122 shares and covered exercise/tax liability with 144,576 shares, increasing direct ownership by 26% to 1,692,333 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Apr 28, 2023SNCESEC Form 4 filed by Coman DavidForm 4Grant or awardSale back to the company
- Aug 12, 2022SNCESEC Form 4 filed by Coman DavidForm 4Grant or award
- Jan 7, 2022SNCESEC Form 4 filed by Coman DavidForm 4Grant or award
- Oct 7, 2021LSAQSEC Form 4 filed by Coman David (Amendment)Form 4Grant or award
- Oct 6, 2021LSAQSEC Form 4: Coman David was granted 723,320 sharesForm 4Grant or award
- Oct 6, 2021LSAQDavid Coman became an insiderForm 3New insider
Also sits on boards with
Officers and directors who share two or more companies with David Coman.
- Jonathan Cotliar2 shared: SNCE, LSAQ
- Darcy Forman2 shared: SNCE, LSAQ
- Mike Zaranek2 shared: SNCE, LSAQ
- Christine A Pellizzari2 shared: SNCE, LSAQ
- Steven Geffon2 shared: SNCE, LSAQ
- Adam Goulburn2 shared: SNCE, LSAQ
Compare David Coman with
- David Coman vs Robert C. Faulkner2 shared
- David Coman vs Jonathan Cotliar2 shared
- David Coman vs Darcy Forman2 shared
- David Coman vs Mike Zaranek2 shared
- David Coman vs Christine A Pellizzari2 shared
- David Coman vs Neil Tiwari2 shared
Questions about David Coman
- What is David Coman's role at Science 37 Holdings, Inc.?
- David Coman reports to the SEC as chief Executive Officer at Science 37 Holdings, Inc. (SNCE), according to the latest filing on March 12, 2024. David Coman has also filed as officer and director at Science 37 Holdings, Inc. (LSAQ).
- How many shares does David Coman own?
- After the latest filing that states it, David Coman directly owned 726,137 shares of Science 37 Holdings, Inc. (LSAQ). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has David Coman bought or sold stock recently?
- No open-market purchases or sales by David Coman are on file. The filings report sale back to the company, tender of shares in a change of control, shares withheld for taxes or exercise price and exercise or conversion of a derivative.
- How do I get alerts when David Coman files?
- Follow David Coman on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by David Coman (SEC CIK 0001886837). Totals count each trade once, skipping amendments whose original is on file, from Oct 9, 2021 on. View on SEC EDGAR